Profound Medical (TSE:PRN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Profound Medical is set to release its third quarter financial results on November 7, inviting investors to a conference call to discuss the details. The company specializes in incision-free medical therapies, including the TULSA-PRO® system for prostate treatment and Sonalleve® for uterine fibroids and bone metastases.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.